Search

everythinglearnresearchcommunity

for

Search:↓

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

New cancer treatments aim to reduce side effects and improve effectiveness.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Most patients experienced significant but reversible hair loss during treatment.

Cimetidine did not reduce hair growth in women with hirsutism.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

DNA methylation of miR-365-1 causes hair follicle stem cell death by affecting DAP3.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.